Introduction
The idea that aberrant cell behaviour can be pinpointed to critical molecular modifications has gained elegant experimental support in studies showing specific nucleic and corresponding amino acid changes in inherited disorders in haemoglobin synthesis and structure. The realization that many physiological processes are membrane mediated, coupled with progress in knowledge of the structure and function of biological membranes, has encouraged many investigators to study membrane pathology. The plasma membrane is positioned strategically for modification by intra-and extracellular factors. The easy availability and relative simplicity of erythrocyte membranes has already led to the demonstration of membrane changes in genetic and infectious diseases, and two recent examples include those detected in haemoglobinuria (Banga, Pinder, Gratzer, Linch & Huehns, 1979) and aRcr infection by malaria sporozoites (Wallach, 1979) . The plasma membrane of nucleated cells, and especially those constituting tissues and organs, is a far more complex organelle. In addition to its various transport functions, the plasma membrane has been shown to be a primary site of action of polypeptide hormones, viruses, drugs and toxins. The plasma membrane's outer surface is also a key component in controlling cell-cell interactions, as well as cell, organ and tissue specificity.
The metabolic versatility of the hepatocyte is reflected at its cell surface, where the plasma membrane is differentiated into at least three major anatomical and functional regions. The plasma membrane at the blood-interfacing sinusoidal and bile-interfacing canalicular regions forms microvilli and these two regions are separated by smooth (Evans, 1978 (Evans, , 1980 , and studies on pathobiochemical modifications have to be assessed, in the knowledge that many cell-surface functions are confined to specific plasma-membrane regions. Since hepatocytes function in the removal of blood-borne constituents, some of which are translocated across the cell interior and released into bile, it is likely that mechanisms operate that feature long-distance interactions between blood-and bile-interfacing plasma-membrane domains, via membrane-delineated pathways traversing the hepatocyte interior. This route is in addition to the tight-junction mediated extracellular shunt between blood and bile (Layden, Elias & Boyer, 1978) .
This present review, which highlights recent progress in studying diseased hepatic plasma membranes, is divided into four sections covering aspects of hepatobiliary diseases, hormone-receptor modifications, malignancy and toxin-induced damage.
Hcpato-biliary diseases
The fact that liver plasma-membrane fractions prepared from 'low-speed' pellets by the classical procedures of Neville, Emmelot, Song and their variants (see Evans, 1977 Evans, , 1980 are particularly enriched in bile canalicular complexes, has encouraged studies on the modifications leading to, or resulting from, cholestasis or choleresis. The bile canalicular region of the plasma membrane is continuous with, but segregated from, the remainder of the hepatocyte's plasma membrane by tight junctions (Motta, Muto & Fujita, 1978) , 1979) . At the biochemical level, the early consequences of extrahepatic cholestasis produced by bile-duct ligation include a general decrease in activity of plasmamembrane enzymes, including 5'-nucleotidase, alkaline phosphodiesterase and leucine aminopeptidase. However, both alkaline phosphatase and catecholamine-sensitive adenylate cyclase activities and P-adrenoreceptor number increase (Toda, Oka, Oda & Ikeda, 1975; Schmelck, Billon, Munnich, Geynet, Houssin & Hanoune, 1979) . Since the bile acid-independent component of canalicular bile flow is a Na+-dependent process (Erlinger & Dhumeaux, 1974) , the Na+/K+-activated ATPase has been studied extensively. Oestrogen-induced intrahepatic cholestasis reduces Na+/K+-activated ATPase activity in bile canaliculi-containing plasma-membrane fractions, possibly as a result of changes in membrane fluidity measured by fluorescence polarization (Davis, Kern, Showalter, Sutherland, Sinensky & Simon, 1978; Keeffe, Scharschmidt, Blankenship & Ockner, 1979) . However, recent cytochemical (Blitzer & Boyer, 1978) and biochemical evidence (Poupon & Evans, 1979) points to a lateral and not a canalicular location for Na+/K+-activated ATPase activity on the hepatocyte surface and a paracellular pathway, rather than a direct, single enzyme-modulated release of Na+ across the membrane into bile, appears likely. These most recent observations emphasize that concepts of bile formation need reevaluation, and that a better understanding of plasma-membrane functional topography is an essential prerequisite for identification of biochemical factors underlying pathological changes.
The bile canalicular plasma membrane has a different biochemical composition to the remainder of the plasma mambrane (Evans, Kremmer & Culvenor, 1976; Kremmer, Wisher & Evans, 1976) : the possible derivation of bile lipids from the canalicular membrane by synthesis (Yousef, Fisher, Piekarski & Holub, 1977) or selective abrasive-dissolution by bile salts during or after secretion into bile spaces, now appears unlikely (Vyvoda, Coleman & Holdsworth, 1977; Evans & Higgins, 1979) . With identification of the two major proteins of rodent bile as immunoglobulin A and y,-globulin (Mullock, Dobrota & Hinton, 1978) , attention is re-focused on a range of new intracellular factors regulating hepatic bile formation. Receptors for bile acids (Gonzalez, Sutherland & Simon, 1979) and immunoglobulin A (Hopf, Mutschall & Meyerzumbuschenfelde, 1979; Kuhn & Kraehenbuhl, 1979) at the bloodsinusoidal plasma membrane remove these constituents from blood, and a population of plasmamembrane-derived intracellular vesicles (Mullock, Hinton, Dobrota, Peppard & Orlans, 1979) emerge as possible candidates for shuttling metabolites across the hepatocyte to the biliary region. Clearly, attempts to study the pathogenesis of bile formation and flow have leapt ahead of our knowledge of hepatocyte plasma-membrane biochemistry and the mechanisms underlying epithelial transport.
Hormone-receptor modifications
Liver plasma membranes possess specific binding sites for angiotensin, insulin, prolactin, growth hormone, prostaglandins, thyroxine, oestrogens, catecholamines and glucagon (Baxter & Funder, 1979; Jones, Vierling, Steer & Reichen, 1979) . Hormone-receptor protein interactions result in information being transferred into the cell interior. Glucagon and catecholamine binding stimulate the production of cyclic AMP at the inner surface of the plasma membrane but, with other hormones influencing hepatic metabolism, the more immediate consequences of hormone-receptor interactions are unclear. Insulin binding to the hepatocyte cell surface is followed by rapid internalization of the hormone, presumably still attached to its receptor, and radioautographical and biochemical studies suggest processing at Golgi, lysosome and nuclear membrane locations (Bergeron, Posner, Josefsberg & Sikstrom, 1978; Carpentier, Gorden, Barazzone, Freychet, Lecam & Orci, 1979; Horvat, 1978) . This implies rapid and specific interactions between insulin attached to plasmamembrane-derived components and various intracellular membrane components and opens up a new repertoire of possible sites of primary action.
The concept of receptor-related diseases has gained acceptance with the demonstration of the impaired receptor-binding activity of plasma membranes in various hormonally induced syndromes. Thus derangements of insulin receptors in liver plasma membrane fractions have been detected in several states of insulin resistance and hyperinsulinaemia including obesity (Verhoeven & Wilson, 1979) . For example, with liver plasma membranes from insulin-treated diabetic rats, increases in glucagon binding and glucagon-stimulated adenylate cyclase activity were shown when insulin binding was decreased (Soman & Felig, 1978 
1980).
Success with receptor purification has been hindered by their paucity, hydrophobicity and the tendency of hormone-receptor complexes to dissociate in many detergents used to solubiliie membranes. Polypeptide hormones labelled with photo-atlinity reagents can allow covalent binding of hormone-receptor complexes, and the purification of the hepatic insulin receptor by this methodology has now been reported (Jacobs, Hazum, Schechter & Cuatrecasas, 1979). The possibility of exploring molecular modification of receptors in hormone-linked diseases is now in prospect.
Malignancy and growth control
Cell-surface modifications frequently lead to the disruption of homeostatic mechanisms, and plasma-membrane aberrations in malignancy have been investigated intensively (Wallach, 1978) . Studies on growth control in liver at the plasma membrane level have used regenerating tissue as a model system because of the rapid hepatocyte division (Sirica, Goldblatt & McKelvy, 1977; Wright, 1977 Blitterswijk & Emmelot, 1979) and enzyme activities have been described. The interpretation of any differences in properties observed between liver and hepatoma membranes is subject to homogenate variations on subcellular fractionation of differentiated hepatocytes and partially or totally de-differentiated hepatoma tissue or cell lines. As already noted, the plasma-membrane fragments originating from the hepatocyte's three major functional domains possess differing biochemical and physical properties; approaches featuring a study of single-membrane fractions are subject to the criticism that factors secondary to or unrelated to those inducing malignant behaviour are compared. However, analysis of relationships between rates of glycosylation of membrane glycoconjugates and malignant transformation, by studying membrane fucoprotein biosynthesis and turnover in liver and hepatoma, can identify defects leading to modified cell surface specificity (Vischer & Reutter, 1978) .
Differences in cell-cell interactions at the level of gap junctions (discrete permeable plasma-membrane regions facilitating direct transfer of ions and small molecules between cells in contact) have often been associated with a change towards malignancy (Lowenstein, 1979) . Any general association between malignancy and defects in gap-junctionmediated intercellular communication has been shown to be subject to many exceptions (Weinstein, Merk & Alroy, 1976) and it is noted that reduced numbers of junctions are observed not only in hepatoma, but also in regenerating anoxic, and hypoxic liver tissue (Yancey, Easter & Revel, 1979) .
Drug-and toxin-induced plasma-membrane modifications
Toxin-and drug-induced hepatic changes are well documented histologically, and many investigators have sought to identify biochemical changes in membranes that precede the onset of cirrhosis, fibrosis and necrosis.
A variety of changes in plasma-membrane fractions prepared from animals given various toxins are reported. These include such diverse effects as: carbon tetrachloride-induced changes in phospholipid metabolism and membrane enzymes (Isutsu & Smuckler, 1978; Mourelle & Rubalcava, 1979) ; phenobarbital-induced changes in plasmamembrane enzymes, and the number of insulin and glucagon receptors (Kamath & Rubin, 1974; Mourelle & Rubalcava, 1979) ; the inhibition by chloropromazine of the aggregation of intra- Bertrand, Veissiere & Pickard, 1979) . These diverse effects of drugs and toxins on hepatic plasma membranes are probably a consequence of general damage to the integrity of intracellular membrane systems especially the extensive endoplasmic reticular components (Fig.  1) . The effects of phallotoxins (present in poisonous mushroom species) on liver cells illustrate how investigations on the mechanism of action of hepatotoxins are directed increasingly towards their primary molecular site of action. Administration of phallotoxins leads to cholestasis and a rapid loss of plasma-membrane sinusoidal and canalicular microvilli. Phallotoxins bind to actin subunits of the microfilaments and this leads rapidly to wide-ranging physiological perturbations (Wieland & Faulstich, 1978) . Cytochalasin also appears to disrupt microfilaments, as it interferes with actin polymerization by inhibiting the growth of actin filaments (Grumet, Flanagan, Lin & Lin, 1979) . Indeed, disturbances in cytoskeletal elements interacting with the inner surface Hepatic plasma membrane in disease 443 of the plasma membrane, and involved in controlling the lateral movement of many plasma membrane receptors, microvillar exocytosis and endocytosis, are emerging as likely prime targets of many hepatotoxic agents. It is to be expected that further investigations will result in agents modifying hepatocyte plasma-membrane properties, being classified according to their action on plasma membrane bilayer constituents, or on the peripheral appendages such as cytoskeletal elements and extracellular matrix components, e.g. fibronectin and collagen.
Conclusion
Although a wide spectrum of biochemical modifications of the plasma membrane are reported to occur in a variety of diseases of the hepato-biliary system, the present review indicates that identification of the critical points at which molecular lesions occur is hindered in many respects by our lack of precise knowledge of the membrane biology of hepatocytes. Changes in membrane properties reported for composition, enzymology, fluidity and receptor numbers can be regarded as reflecting disturbances in mechanisms controlling membrane biogenesis and turnover. Among the factors controlling plasma membrane dynamics are the cytoskeletal elements modulating functions via the cytoplasmic face, and the various components of the extracellular matrix impinging on the outer surface. It should also be pointed out that many liver processes are now attributed to endothelial, Kupffer and stellate cells, and interactions between these and hepatocytes (Wanson, Mosselmans, Brouwer & Knook, 1979) are further areas open to modification in disease.
Cytogenetic techniques will also feature increasingly to identify the chromosomal position and structure of genes controlling specific plasmamembrane phenotypes. Early candidates for combined biochemical and genetical analyses are the histocompatibility antigens recently purified from liver (Henriksen, Robinson & Appella, 1979) , especially since they may be important determinants where immune reactions are implicated in pathogenesis.
